Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Epithelial Tumor, Malignant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT03685591
What this trial is testing

PF-06952229 Treatment in Adult Patients With Advanced Solid Tumors

Who this might be right for
Breast NeoplasmsProstate NeoplasmsNeoplasms, Squamous Cell+6 more
Pfizer 49
Testing effectiveness (Phase 2)WithdrawnNCT01913691
What this trial is testing

Study of the Drug Ipilimumab for Metastatic Merkel Cell Carcinoma

Who this might be right for
Merkel Cell Carcinoma
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00085813
What this trial is testing

Ispinesib In Patients With Advanced Or Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Non-Small-Cell Lung Cancer
GlaxoSmithKline 70
Not applicableNot Yet RecruitingNCT07189624
What this trial is testing

Effect of Acute Endurance Exercise on the Production of FGF21 and Follistatin in Patients With Hepatocellular Carcinoma

Who this might be right for
Cirrhosis With Hepatocellular Carcinoma
University Hospital, Clermont-Ferrand 12
Very early researchStudy completedNCT03196180
What this trial is testing

Topical Fluorouracil and Imiquimod in Treating Patients With High-Grade Cervical Intraepithelial Neoplasia

Who this might be right for
Cervical Intraepithelial Neoplasia Grade 2/3Cervical Squamous Cell Carcinoma In SituCervical Squamous Intraepithelial Neoplasia 2+1 more
National Cancer Institute (NCI) 13
Not applicableEnded earlyNCT01617980
What this trial is testing

Multimodal Hypoxia Imaging and Intensity Modulated Radiotherapy for Inoperable Non-small-cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
German Cancer Research Center 4
Testing effectiveness (Phase 2)Study completedNCT01024946
What this trial is testing

Everolimus (RAD001) for the Treatment of Malignant Pleural Mesothelioma With Merlin/NF2 Loss as a Biomarker to Predict Sensitivity

Who this might be right for
Malignant Pleural Mesothelioma
Memorial Sloan Kettering Cancer Center 11
Post-approval studies (Phase 4)UnknownNCT01758679
What this trial is testing

A Clinical Trail of Iodine[131I] Metuximab Injection With CIK Cells for Preventing Hepatocellular Carcinoma

Who this might be right for
Multiple Drug Use
Tianjin Medical University Cancer Institute and Hospital 120
Early research (Phase 1)Study completedNCT02303678
What this trial is testing

D2C7 for Adult Patients With Recurrent Malignant Glioma

Who this might be right for
Malignant GliomaBrain Tumor, Recurrent
Darell Bigner 81
Not applicableLooking for participantsNCT03785743
What this trial is testing

Comparing Laparoscopic and Open Surgery for Pancreatic Carcinoma

Who this might be right for
Pancreatic CarcinomaLaparoscopicPancreaticoduodenectomy
Tongji Hospital 200
Large-scale testing (Phase 3)Study completedNCT02366143
What this trial is testing

Atezolizumab in Combination With Carboplatin Plus (+) Paclitaxel With or Without Bevacizumab Compared With Carboplatin+Paclitaxel+Bevacizumab in Participants With Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Hoffmann-La Roche 1,202
Testing effectiveness (Phase 2)Looking for participantsNCT06802835
What this trial is testing

EGFR Antibody Combined With PD-1 Inhibitor and Chemotherapy in R/M Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Cancinoma (NPC)Recurrent Nasopharynx CarcinomaMetastatic Nasopharyngeal Carcinoma
Sun Yat-sen University 148
Early research (Phase 1)Active Not RecruitingNCT06005740
What this trial is testing

A Phase 1, First in Human Study of TORL-4-500 in Patients With Advanced Cancer

Who this might be right for
Advanced Solid TumorHepatocellular Carcinoma
TORL Biotherapeutics, LLC 70
Early research (Phase 1)Study completedNCT02159989
What this trial is testing

Sapanisertib and Ziv-Aflibercept in Treating Patients With Recurrent Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery

Who this might be right for
Advanced Malignant Solid NeoplasmFibrolamellar CarcinomaMetastatic Malignant Solid Neoplasm+5 more
National Cancer Institute (NCI) 83
Early research (Phase 1)Study completedNCT00006368
What this trial is testing

Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer

Who this might be right for
Brain and Central Nervous System TumorsBreast CancerGastrointestinal Carcinoid Tumor+5 more
Novartis Pharmaceuticals 60
Not applicableStudy completedNCT02595450
What this trial is testing

A Non-interventional Trial of Erlotinib (Tarceva) Metastatic Non-small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Hoffmann-La Roche 299
Large-scale testing (Phase 3)Active Not RecruitingNCT06569420
What this trial is testing

Study Of Comparing SAF-189s With Crizotinib In First Line ALK-Positive Advanced and Metastatic NSCLC

Who this might be right for
Non-Small Cell Lung CancerALK-positiveSAF-189s
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. 275
Early research (Phase 1)Study completedNCT03470259
What this trial is testing

Precision Thyroid Cancer Surgery With Molecular Fluorescent Guided Imaging

Who this might be right for
Papillary Thyroid CancerLymph Node Metastases
University Medical Center Groningen 19
Testing effectiveness (Phase 2)UnknownNCT03983759
What this trial is testing

Study of Sintlimab Maintenance Therapy in Patients With Extensive Small Cell Lung Cancer

Who this might be right for
Small Cell Lung CancerExtensive DiseaseAdoptive Cellular Immunotherapy+2 more
Henan Cancer Hospital 40
Large-scale testing (Phase 3)Active Not RecruitingNCT04765059
What this trial is testing

Evaluate Chemotherapy Plus Osimertinib Against Chemotherapy Plus Placebo in Patients With Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-small Cell Lung Cancer
AstraZeneca 98
Next Page